PROMISING PSYCHOPHARMACOLOGICAL MEDICATIONS NOT AVAILABLE IN THE USA

被引：0
|
作者：
GLICK, ID [1 ]
LECRUBIER, Y [1 ]
MONTGOMERY, S [1 ]
VINAR, O [1 ]
KLEIN, DF [1 ]
机构：
[1] STANFORD UNIV,MED CTR,DEPT PSYCHIAT,STANFORD,CA 94305
来源：
SCHIZOPHRENIA RESEARCH | 1995年 / 15卷 / 1-2期
关键词：
D O I：
10.1016/0920-9964(95)95469-P
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：151 / 151
页数：1
相关论文
共 50 条
  • [1] PROMISING MEDICATIONS NOT AVAILABLE IN THE UNITED-STATES
    GLICK, ID
    VINAR, O
    KLEIN, DF
    POTTER, WZ
    MONTGOMERY, SA
    LECRUBIER, Y
    BIOLOGICAL PSYCHIATRY, 1994, 35 (09) : 678 - 678
  • [2] PSYCHOPHARMACOLOGICAL ISSUES IN ORGAN-TRANSPLANTATION .2. PSYCHOPHARMACOLOGICAL MEDICATIONS
    TRZEPACZ, PT
    DIMARTINI, A
    TRINGALI, RD
    PSYCHOSOMATICS, 1993, 34 (04) : 290 - 298
  • [3] Psychopharmacological interventions in mixed states: available evidence and clinical reality
    Haddad, P.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2017, 27 : S1131 - S1131
  • [4] Herbal Insomnia Medications that Target GABAergic Systems: A Review of the Psychopharmacological Evidence
    Shi, Yuan
    Dong, Jing-Wen
    Zhao, Jiang-He
    Tang, Li-Na
    Zhang, Jian-Jun
    CURRENT NEUROPHARMACOLOGY, 2014, 12 (03) : 289 - 302
  • [5] ANTIPSYCHOTIC AND PSYCHOPHARMACOLOGICAL MEDICATIONS: CARE TRANSITIONS AMONG NURSING HOME RESIDENTS
    Holmes, Sarah
    Kuzucan, Aida
    Olopoenia, Abisola
    Brandt, Nicole
    Briesacher, Becky
    Qato, Danya
    Zarowitz, Barbara
    Wastila, Linda
    INNOVATION IN AGING, 2021, 5 : 90 - 91
  • [6] A CLINICAL BASED SYNOPSIS OF AVAILABLE PSYCHOPHARMACOLOGICAL TREATMENT IN HUNTINGTON'S DISEASE
    Caletti, Elisabetta
    Zugno, Elisa
    Botturi, Andrea
    Prunas, Cecilia
    Cigliobianco, Michela
    Paoli, Riccardo Augusto
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2016, 87 : A72 - A72
  • [7] International update: New findings on promising medications
    Litten, RZ
    Fertig, J
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 1996, 20 (08) : A216 - A218
  • [8] Schizophrenia and Nicotine Dependence: What Psychopharmacological Treatment Options are Available for the Duo Perturbationes?
    Yoong Mei Theng
    Wahab, Suzaily
    Wahab, Noor Alaudin A.
    Sidi, Hatta
    Das, Srijit
    CURRENT DRUG TARGETS, 2019, 20 (02) : 173 - 181
  • [9] Educating and Informing Patients Receiving Psychopharmacological Medications: Are Family Physicians in Pakistan up to the Task?
    Ganatra, Hammad Ashraf
    Bhurgri, Hadi
    Channa, Roomasa
    Bawany, Fauzia Ahmad
    Zafar, Syed Nabeel
    Chaudhry, Rafia Ishfaq
    Batool, Syeda Hina
    Basit, Abdul
    Asghar, Mehmood
    Saleem, Sarah
    Naqvi, Haider
    PLOS ONE, 2009, 4 (02):
  • [10] Factors influencing adherence to psychopharmacological medications in psychiatric patients: a structural equation modeling approach
    De las Cuevas, Carlos
    de Leon, Jose
    Penate, Wenceslao
    Betancort, Moises
    PATIENT PREFERENCE AND ADHERENCE, 2017, 11 : 681 - 690
12345